메뉴 건너뛰기




Volumn 99, Issue 2, 2014, Pages

Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; BONE MORPHOGENETIC PROTEINS; CASE-CONTROL STUDIES; FEMALE; FRACTURES, BONE; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; OSTEOGENESIS IMPERFECTA; PROCOLLAGEN;

EID: 84893737543     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2244     Document Type: Article
Times cited : (14)

References (42)
  • 2
    • 0018416379 scopus 로고
    • Genetic heterogeneity in osteogenesis imperfecta
    • Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101-116.
    • (1979) J Med Genet. , vol.16 , pp. 101-116
    • Sillence, D.O.1    Senn, A.2    Danks, D.M.3
  • 3
    • 84874106867 scopus 로고    scopus 로고
    • Femoral geometric parameters and bmd measurements by dxa in adult patients with different types of osteogenesis imperfecta
    • Kocijan R, Muschitz C, Fratzl-Zelman N, et al. Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta. Skeletal Radiol. 42:187-194.
    • Skeletal Radiol. , vol.42 , pp. 187-194
    • Kocijan, R.1    Muschitz, C.2    Fratzl-Zelman, N.3
  • 5
    • 22844445934 scopus 로고    scopus 로고
    • Sost is a ligand for lrp5/lrp6 and a wnt signaling inhibitor
    • Semenov M, Tamai K, He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem. 2005;280:26770-26775.
    • (2005) J Biol Chem. , vol.280 , pp. 26770-26775
    • Semenov, M.1    Tamai, K.2    He, X.3
  • 6
    • 4644227529 scopus 로고    scopus 로고
    • Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis
    • Ohyama Y, Nifuji A, Maeda Y, Amagasa T, Noda M. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis. Endocrinology. 2004;145:4685-4692.
    • (2004) Endocrinology. , vol.145 , pp. 4685-4692
    • Ohyama, Y.1    Nifuji, A.2    Maeda, Y.3    Amagasa, T.4    Noda, M.5
  • 7
    • 77957846460 scopus 로고    scopus 로고
    • Relation of age, gender, and bone mass to circulating sclerostin levels in women and men
    • Modder UI, Hoey KA, Amin S, et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res. 2011;26:373-379.
    • (2011) J Bone Miner Res. , vol.26 , pp. 373-379
    • Modder, U.I.1    Hoey, K.A.2    Amin, S.3
  • 8
    • 84855474270 scopus 로고    scopus 로고
    • Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults
    • Amrein K, Amrein S, Drexler C, et al. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab. 2012; 97:148-154.
    • (2012) J Clin Endocrinol Metab. , vol.97 , pp. 148-154
    • Amrein, K.1    Amrein, S.2    Drexler, C.3
  • 9
    • 77952771209 scopus 로고    scopus 로고
    • Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss
    • Gaudio A, Pennisi P, Bratengeier C, et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab. 2010;95:2248-2253.
    • (2010) J Clin Endocrinol Metab. , vol.95 , pp. 2248-2253
    • Gaudio, A.1    Pennisi, P.2    Bratengeier, C.3
  • 11
    • 81855184668 scopus 로고    scopus 로고
    • Determinants of serum sclerostin in healthy pre- and postmenopausal women
    • Ardawi MS, Al-Kadi HA, Rouzi AA, Qari MH. Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res. 2011;26:2812-2822.
    • (2011) J Bone Miner Res. , vol.26 , pp. 2812-2822
    • Ardawi, M.S.1    Al-Kadi, H.A.2    Rouzi, A.A.3    Qari, M.H.4
  • 12
    • 84873726062 scopus 로고    scopus 로고
    • Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: The ofely study
    • Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int. 2013; 24:489-494.
    • (2013) Osteoporos Int. , vol.24 , pp. 489-494
    • Garnero, P.1    Sornay-Rendu, E.2    Munoz, F.3    Borel, O.4    Chapurlat, R.D.5
  • 13
    • 84875186616 scopus 로고    scopus 로고
    • Lower fracture risk in older men with higher sclerostin concentration-A prospective analysis from the minos study
    • Szulc P, Bertholon C, Borel O, Marchand F, Chapurlat R. Lower fracture risk in older men with higher sclerostin concentration-A prospective analysis from the MINOS study. J Bone Miner Res. 2013;28(4):855-864.
    • (2013) J Bone Miner Res. , vol.28 , Issue.4 , pp. 855-864
    • Szulc, P.1    Bertholon, C.2    Borel, O.3    Marchand, F.4    Chapurlat, R.5
  • 14
    • 84861985326 scopus 로고    scopus 로고
    • Serum sclerostin and risk of hip fracture in older caucasian women
    • Arasu A, Cawthon PM, et al. Serum sclerostin and risk of hip fracture in older Caucasian women. J Clin Endocrinol Metab. 2012; 97:2027-2032.
    • (2012) J Clin Endocrinol Metab. , vol.97 , pp. 2027-2032
    • Arasu, A.1    Cawthon, P.M.2
  • 15
    • 84869390060 scopus 로고    scopus 로고
    • High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: The center of excellence for osteoporosis research study
    • Ardawi MS, Rouzi AA, Al-Sibiani SA, Al-Senani NS, Qari MH, Mousa SA. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the center of excellence for osteoporosis research study. J Bone Miner Res. 2012;27:2592-2602.
    • (2012) J Bone Miner Res. , vol.27 , pp. 2592-2602
    • Ardawi, M.S.1    Rouzi, A.A.2    Al-Sibiani, S.A.3    Al-Senani, N.S.4    Qari, M.H.5    Mousa, S.A.6
  • 16
    • 84860128591 scopus 로고    scopus 로고
    • Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south chinese postmenopausal women
    • Sheng Z, Tong D,OuY, et al. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women. Clin Endocrinol (Oxf). 2012;76: 797-801.
    • (2012) Clin Endocrinol (Oxf). , vol.76 , pp. 797-801
    • Sheng, Z.1    Tong, D.2    Ou, Y.3
  • 17
    • 65549152230 scopus 로고    scopus 로고
    • Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis
    • Li X, Ominsky MS, Warmington KS, et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res. 2009; 24:578-588.
    • (2009) J Bone Miner Res. , vol.24 , pp. 578-588
    • Li, X.1    Ominsky, M.S.2    Warmington, K.S.3
  • 18
    • 84867336111 scopus 로고    scopus 로고
    • Newtherapeutic targets for osteoporosis: Beyond denosumab
    • Lim V, Clarke BL.Newtherapeutic targets for osteoporosis: beyond denosumab. Maturitas. 2012;73:269-272.
    • (2012) Maturitas. , vol.73 , pp. 269-272
    • Lim, V.1    Clarke, B.L.2
  • 20
    • 84857440881 scopus 로고    scopus 로고
    • Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women-The six-month effect of risedronate and teriparatide
    • Polyzos SA, Anastasilakis AD, Bratengeier C, Woloszczuk W, Papatheodorou A, Terpos E. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women-The six-month effect of risedronate and teriparatide. Osteoporos Int. 2012;23:1171-1176.
    • (2012) Osteoporos Int. , vol.23 , pp. 1171-1176
    • Polyzos, S.A.1    Anastasilakis, A.D.2    Bratengeier, C.3    Woloszczuk, W.4    Papatheodorou, A.5    Terpos, E.6
  • 21
    • 84880148878 scopus 로고    scopus 로고
    • The association between insulin-like growth factor i and bone turnover markers in the general adult population
    • Niemann I, Hannemann A, NauckM,et al. The association between insulin-like growth factor I and bone turnover markers in the general adult population. Bone. 2013;56:184-190.
    • (2013) Bone. , vol.56 , pp. 184-190
    • Niemann, I.1    Hannemann, A.2    Nauck, M.3
  • 22
    • 84863710246 scopus 로고    scopus 로고
    • Evaluation of ids-isys intact parathyroid hormone (ipth) and comparison to siemens advia centaur ipth assay in chronic renal failure patients and in controls
    • Koivula MK, Laitinen P, Risteli J. Evaluation of IDS-iSYS intact parathyroid hormone (iPTH) and comparison to Siemens Advia Centaur iPTH assay in chronic renal failure patients and in controls. Clin Lab. 2012;58:403-410.
    • (2012) Clin Lab. , vol.58 , pp. 403-410
    • Koivula, M.K.1    Laitinen, P.2    Risteli, J.3
  • 23
    • 84876544339 scopus 로고    scopus 로고
    • Four automated 25-oh total vitamin d immunoassays and commercial liquid chromatography tandem-mass spectrometry in finnish population
    • Koivula MK, Matinlassi N, Laitinen P, Risteli J. Four automated 25-OH total vitamin D immunoassays and commercial liquid chromatography tandem-mass spectrometry in Finnish population. Clin Lab. 2013;59:397-405.
    • (2013) Clin Lab. , vol.59 , pp. 397-405
    • Koivula, M.K.1    Matinlassi, N.2    Laitinen, P.3    Risteli, J.4
  • 24
    • 1642443472 scopus 로고    scopus 로고
    • Performance evaluation of automated assays for -crosslaps, n-mid-osteocalcin and intact parathyroid hormone (biorose multicenter study
    • Schmidt-Gayk H, Spanuth E, Kotting J, et al. Performance evaluation of automated assays for -CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study). Clin Chem Lab Med. 2004;42:90-95.
    • (2004) Clin Chem Lab Med. , vol.42 , pp. 90-95
    • Schmidt-Gayk, H.1    Spanuth, E.2    Kotting, J.3
  • 25
    • 78651076679 scopus 로고    scopus 로고
    • In vivo precision of the ge lunar idxa densitometer for the measurement of total body composition and fat distribution in adults
    • Hind K, Oldroyd B, Truscott JG. In vivo precision of the GE Lunar iDXA densitometer for the measurement of total body composition and fat distribution in adults. Eur J Clin Nutr. 2011;65:140-142.
    • (2011) Eur J Clin Nutr. , vol.65 , pp. 140-142
    • Hind, K.1    Oldroyd, B.2    Truscott, J.G.3
  • 26
    • 0034022769 scopus 로고    scopus 로고
    • Static and dynamic bone histomorphometry in children with osteogenesis imperfecta
    • Rauch F, Travers R, Parfitt AM, Glorieux FH. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. 2000;26:581-589.
    • (2000) Bone. , vol.26 , pp. 581-589
    • Rauch, F.1    Travers, R.2    Parfitt, A.M.3    Glorieux, F.H.4
  • 27
    • 56749095463 scopus 로고    scopus 로고
    • Cellular mechanism of decreased bone in brtl mouse model of oi: Imbalance of decreased osteoblast function and increased osteoclasts and their precursors
    • Uveges TE, Collin-Osdoby P, Cabral WA, et al. Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. J Bone Miner Res. 2008;23:1983-1994.
    • (2008) J Bone Miner Res. , vol.23 , pp. 1983-1994
    • Uveges, T.E.1    Collin-Osdoby, P.2    Cabral, W.A.3
  • 28
    • 33746088003 scopus 로고    scopus 로고
    • Bone tissue in osteogenesis imperfecta: Light and electron microscopic studies]
    • Osipenkova-Vichtomova TK. [Bone tissue in osteogenesis imperfecta: light and electron microscopic studies]. Arkhiv Patologii. 2006;68:20-25.
    • (2006) Arkhiv Patologii. , vol.68 , pp. 20-25
    • Osipenkova-Vichtomova, T.K.1
  • 29
    • 26844469532 scopus 로고    scopus 로고
    • Musculoskeletal manifestations of mild osteogenesis imperfecta in the adult
    • McKiernan FE. Musculoskeletal manifestations of mild osteogenesis imperfecta in the adult. Osteoporos Int. 2005;16:1698-1702.
    • (2005) Osteoporos Int. , vol.16 , pp. 1698-1702
    • McKiernan, F.E.1
  • 30
    • 84890155703 scopus 로고    scopus 로고
    • Functioning and quality of life in adults with mild-To-moderate osteogenesis imperfecta [published online december 27, 2012]
    • doi: 10.1002/pri.1546
    • Balkefors V, Mattsson E, Pernow Y, Saaf M. Functioning and quality of life in adults with mild-To-moderate osteogenesis imperfecta [published online December 27, 2012]. Physiother Res Int. doi: 10.1002/pri.1546.
    • Physiother Res Int
    • Balkefors, V.1    Mattsson, E.2    Pernow, Y.3    Saaf, M.4
  • 32
    • 69549096354 scopus 로고    scopus 로고
    • Osteogenesis imperfecta: Recent findings shed new light on this once well-understood condition
    • Basel D, Steiner RD. Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition. GenetMed. 2009; 11:375-385.
    • (2009) GenetMed. , vol.11 , pp. 375-385
    • Basel, D.1    Steiner, R.D.2
  • 33
    • 34249866221 scopus 로고    scopus 로고
    • Bone formation markers in adults with mild osteogenesis imperfecta
    • Cundy T, Horne A, Bolland M, Gamble G, Davidson J. Bone formation markers in adults with mild osteogenesis imperfecta. Clin Chem. 2007;53:1109-1114.
    • (2007) Clin Chem. , vol.53 , pp. 1109-1114
    • Cundy, T.1    Horne, A.2    Bolland, M.3    Gamble, G.4    Davidson, J.5
  • 34
    • 59649092309 scopus 로고    scopus 로고
    • Bone turnover and type i collagen c-Telopeptide isomerization in adult osteogenesis imperfecta: Associations with collagen gene mutations
    • Garnero P, Schott AM, Prockop D, Chevrel G. Bone turnover and type I collagen C-Telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations. Bone. 2009; 44:461-466.
    • (2009) Bone. , vol.44 , pp. 461-466
    • Garnero, P.1    Schott, A.M.2    Prockop, D.3    Chevrel, G.4
  • 35
    • 70449345629 scopus 로고    scopus 로고
    • Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of pinp with fracture reduction in postmenopausal women with osteoporosis
    • Delmas PD, Munoz F, Black DM, et al. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis. J Bone Miner Res. 2009;24:1544-1551.
    • (2009) J Bone Miner Res. , vol.24 , pp. 1544-1551
    • Delmas, P.D.1    Munoz, F.2    Black, D.M.3
  • 36
    • 33847734705 scopus 로고    scopus 로고
    • Prolonged bisphosphonate release after treatment in children
    • Papapoulos SE, Cremers SC. Prolonged bisphosphonate release after treatment in children. N Engl J Med. 2007;356:1075-1076.
    • (2007) N Engl J Med. , vol.356 , pp. 1075-1076
    • Papapoulos, S.E.1    Cremers, S.C.2
  • 37
    • 0036250837 scopus 로고    scopus 로고
    • Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
    • Astrom E, Soderhall S. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child. 2002;86:356-364.
    • (2002) Arch Dis Child. , vol.86 , pp. 356-364
    • Astrom, E.1    Soderhall, S.2
  • 38
    • 84857366513 scopus 로고    scopus 로고
    • Risedronate in adults with osteogenesis imperfecta type i: Increased bone mineral density and decreased bone turnover, but high fracture rate persists
    • Bradbury LA, Barlow S, Geoghegan F, et al. Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists. Osteoporos Int. 2012;23:285-294.
    • (2012) Osteoporos Int. , vol.23 , pp. 285-294
    • Bradbury, L.A.1    Barlow, S.2    Geoghegan, F.3
  • 39
    • 84861723097 scopus 로고    scopus 로고
    • Long-Term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women
    • Chung YE, Lee SH, Lee SY, et al. Long-Term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women. Osteoporos Int. 2012;23:1235-1243.
    • (2012) Osteoporos Int. , vol.23 , pp. 1235-1243
    • Chung, Y.E.1    Lee, S.H.2    Lee, S.Y.3
  • 40
    • 84856963771 scopus 로고    scopus 로고
    • Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin
    • Gatti D, Viapiana O, Adami S, Idolazzi L, Fracassi E, Rossini M. Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. Bone. 2012;50:739-742.
    • (2012) Bone. , vol.50 , pp. 739-742
    • Gatti, D.1    Viapiana, O.2    Adami, S.3    Idolazzi, L.4    Fracassi, E.5    Rossini, M.6
  • 41
    • 41949089764 scopus 로고    scopus 로고
    • Mechanical stimulation of bone in vivo reduces osteocyte expression of sost/sclerostin
    • Robling AG, Niziolek PJ, Baldridge LA, et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. 2008;283:5866-5875.
    • (2008) J Biol Chem. , vol.283 , pp. 5866-5875
    • Robling, A.G.1    Niziolek, P.J.2    Baldridge, L.A.3
  • 42
    • 84861316084 scopus 로고    scopus 로고
    • Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type i assessed by high-resolution pqct
    • Folkestad L, Hald JD, Hansen S, Gram J, Langdahl B, Abrahamsen B, Brixen K. Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type I assessed by high-resolution pQCT. J Bone Miner Res. 2012;27:1405-1412.
    • (2012) J Bone Miner Res. , vol.27 , pp. 1405-1412
    • Folkestad, L.1    Hald, J.D.2    Hansen, S.3    Gram, J.4    Langdahl, B.5    Abrahamsen, B.6    Brixen, K.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.